Purchase Order 75N91025P00165

Award Date 1/17/25
Potential Completion Date 2/15/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Newton, MA 02459, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, awarded a $14,390 firm fixed price purchase order to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract is for the delivery of lab instruments, specifically Intera Oncology's branded Intera3000 infusion pumps and other general laboratory equipment, to support the NCI's cancer research programs, including clinical trials and standard care therapy...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc. The $14,790.00 contract is for the delivery of laboratory supplies to support NCI's cancer research programs, clinical trials, and patient care initiatives. Intera Oncology Inc. is a for-profit medical device and laboratory supply company that specializes in providing medical equipment, particularly...
This is a $14,790.00 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract is for the delivery of laboratory supplies to support NCI's cancer research programs, clinical trials, and patient care initiatives. The contract does not have a set-aside designation, indicating open competition. Intera...
This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract, valued at $14,390.00, is for the delivery of laboratory supplies to support NCI's cancer research and patient care programs. The contract has a period of performance from the award date of November 11, 2024 through the ultimate...
This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract, valued at $14,390.00, is for the delivery of laboratory supplies including infusion pumps and other equipment to support NCI's cancer research and treatment programs. Intera Oncology Inc. has an established relationship with NCI, having...
The U.S. Department of Health and Human Services' National Cancer Institute (HHS-NIH-NCI) awarded a $14,390.00 firm fixed price purchase order contract to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract is for the delivery of Intera3000 infusion pumps and other general laboratory equipment to support the NCI's cancer research programs, including clinical trials and standard care therapy for cancer patients. This contract does not have a set-aside...
This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract, valued at $14,390.00, is for the delivery of Intera3000 infusion pumps and other laboratory equipment and supplies to support NCI's cancer research and treatment programs. The contract has no set-aside designation, indicating that Intera...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (HHS-NIH-NCI) to Intera Oncology Inc., a for-profit corporate entity, to provide laboratory supplies and equipment in support of the agency's cancer research efforts. The contract has a potential value of $13,079.21 and a completion date of May 14, 2024. The contract does not have a set-aside designation. Intera Oncology Inc. has...
This federal contract award to Intera Oncology Inc. is a firm fixed price purchase order (Contract # 75N91024P00585) valued at $14,390.00 for the delivery of infusion pumps to the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services. The award has an ultimate completion date of September 23, 2024. Intera Oncology Inc. is a for-profit medical device and laboratory supply company that has been consistently providing specialized equipment to...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a firm fixed price purchase order contract to Intera Oncology Inc., a for-profit organization, to provide infusion pumps and other laboratory equipment and supplies in support of cancer research efforts. The contract has a potential value of $14,390.00 and a completion date of May 20, 2024. No set-aside designation was used for this award. Intera Oncology Inc. has previously...

The National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, awarded a $14,790.00 firm fixed-price purchase order contract to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract is for the provision of laboratory supplies to support NCI's cancer research programs, clinical trials, and patient care initiatives. Intera Oncology Inc. is a consistent supplier of medical devices and laboratory equipment to NCI, including Intera3000 infusion pumps and other specialized laboratory supplies. The contract does not have a set-aside designation, indicating Intera Oncology Inc. competes openly in the federal marketplace. The award is a standalone purchase order contract, not associated with a larger vehicle, with a period of performance through February 15, 2025.

Generated 1/18/25, 9:14 AM